205 related articles for article (PubMed ID: 36153316)
1. Inhibition of USP1 enhances anticancer drugs-induced cancer cell death through downregulation of survivin and miR-216a-5p-mediated upregulation of DR5.
Woo SM; Kim S; Seo SU; Kim S; Park JW; Kim G; Choi YR; Hur K; Kwon TK
Cell Death Dis; 2022 Sep; 13(9):821. PubMed ID: 36153316
[TBL] [Abstract][Full Text] [Related]
2. Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated Mcl-1 Downregulation.
Yoon JY; Woo SM; Seo SU; Song SR; Lee SG; Kwon TK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008442
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship studies of N-benzyl-2-phenylpyrimidin-4-amine derivatives as potent USP1/UAF1 deubiquitinase inhibitors with anticancer activity against nonsmall cell lung cancer.
Dexheimer TS; Rosenthal AS; Luci DK; Liang Q; Villamil MA; Chen J; Sun H; Kerns EH; Simeonov A; Jadhav A; Zhuang Z; Maloney DJ
J Med Chem; 2014 Oct; 57(19):8099-110. PubMed ID: 25229643
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of DR5 and Downregulation of Survivin by IITZ-01, Lysosomotropic Autophagy Inhibitor, Potentiates TRAIL-Mediated Apoptosis in Renal Cancer Cells via Ubiquitin-Proteasome Pathway.
Shahriyar SA; Seo SU; Min KJ; Kubatka P; Min DS; Chang JS; Kim DE; Woo SM; Kwon TK
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825566
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPβ) stability and accelerates adipogenesis and lipid accumulation.
Kim MS; Baek JH; Lee J; Sivaraman A; Lee K; Chun KH
Cell Death Dis; 2023 Nov; 14(11):776. PubMed ID: 38012162
[TBL] [Abstract][Full Text] [Related]
6. Cepharanthine Enhances TRAIL-Mediated Apoptosis Through STAMBPL1-Mediated Downregulation of Survivin Expression in Renal Carcinoma Cells.
Shahriyar SA; Woo SM; Seo SU; Min KJ; Kwon TK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30360403
[TBL] [Abstract][Full Text] [Related]
7. Axl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma.
Woo SM; Min KJ; Seo SU; Kim S; Kubatka P; Park JW; Kwon TK
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31269715
[TBL] [Abstract][Full Text] [Related]
8. Capsaicin sensitizes malignant glioma cells to TRAIL-mediated apoptosis via DR5 upregulation and survivin downregulation.
Kim JY; Kim EH; Kim SU; Kwon TK; Choi KS
Carcinogenesis; 2010 Mar; 31(3):367-75. PubMed ID: 19939880
[TBL] [Abstract][Full Text] [Related]
9. BIX-01294 sensitizes renal cancer Caki cells to TRAIL-induced apoptosis through downregulation of survivin expression and upregulation of DR5 expression.
Woo SM; Seo SU; Min KJ; Kwon TK
Cell Death Discov; 2018 Dec; 4():29. PubMed ID: 29531826
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of ubiquitin-specific protease 1 reveals its importance in hepatocellular carcinoma.
Zhao Y; Xue C; Xie Z; Ouyang X; Li L
Cell Prolif; 2020 Oct; 53(10):e12908. PubMed ID: 32951278
[TBL] [Abstract][Full Text] [Related]
11. A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses.
Liang Q; Dexheimer TS; Zhang P; Rosenthal AS; Villamil MA; You C; Zhang Q; Chen J; Ott CA; Sun H; Luci DK; Yuan B; Simeonov A; Jadhav A; Xiao H; Wang Y; Maloney DJ; Zhuang Z
Nat Chem Biol; 2014 Apr; 10(4):298-304. PubMed ID: 24531842
[TBL] [Abstract][Full Text] [Related]
12. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of USP2 Enhances TRAIL-Mediated Cancer Cell Death through Downregulation of Survivin.
Lee TG; Woo SM; Seo SU; Kim S; Park JW; Chang YC; Kwon TK
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628997
[TBL] [Abstract][Full Text] [Related]
14. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin.
Tse AK; Cao HH; Cheng CY; Kwan HY; Yu H; Fong WF; Yu ZL
J Invest Dermatol; 2014 May; 134(5):1397-1407. PubMed ID: 24213373
[TBL] [Abstract][Full Text] [Related]
15. Maritoclax Enhances TRAIL-Induced Apoptosis via CHOP-Mediated Upregulation of DR5 and miR-708-Mediated Downregulation of cFLIP.
Jeon MY; Min KJ; Woo SM; Seo SU; Choi YH; Kim SH; Kim DE; Lee TJ; Kim S; Park JW; Kwon TK
Molecules; 2018 Nov; 23(11):. PubMed ID: 30463333
[TBL] [Abstract][Full Text] [Related]
16. Magnolol Enhances the Therapeutic Effects of TRAIL through DR5 Upregulation and Downregulation of c-FLIP and Mcl-1 Proteins in Cancer Cells.
Woo SM; Min KJ; Kwon TK
Molecules; 2020 Oct; 25(19):. PubMed ID: 33050112
[TBL] [Abstract][Full Text] [Related]
17. USP1 Is Required for Replication Fork Protection in BRCA1-Deficient Tumors.
Lim KS; Li H; Roberts EA; Gaudiano EF; Clairmont C; Sambel LA; Ponnienselvan K; Liu JC; Yang C; Kozono D; Parmar K; Yusufzai T; Zheng N; D'Andrea AD
Mol Cell; 2018 Dec; 72(6):925-941.e4. PubMed ID: 30576655
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the 'Fingers' subdomain of the deubiquitinase USP1 modulate its function and activity.
Olazabal-Herrero A; García-Santisteban I; Rodríguez JA
FEBS J; 2016 Mar; 283(5):929-46. PubMed ID: 26758085
[TBL] [Abstract][Full Text] [Related]
19. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12.
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564
[TBL] [Abstract][Full Text] [Related]
20. Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance.
Sourisseau T; Helissey C; Lefebvre C; Ponsonnailles F; Malka-Mahieu H; Olaussen KA; André F; Vagner S; Soria JC
Cell Cycle; 2016; 15(2):295-302. PubMed ID: 26825230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
